Prognostic significance of the Cdk5 gene in breast cancer: an in silico study

被引:0
作者
Nafisa Ferdousi Lisany
Mohammad Abu Hena Mostofa Jamal
Hea-Jong Chung
Seong-Tshool Hong
Md. Shahedur Rahman
机构
[1] Jashore University of Science and Technology,Department of Genetic Engineering and Biotechnology
[2] Islamic University,Department of Biotechnology and Genetic Engineering
[3] Chonbuk National University,Department of Biomedical Sciences, Chonbuk National University Medical School
[4] Korea Basic Science Institute,Gwangju Center
来源
Network Modeling Analysis in Health Informatics and Bioinformatics | 2020年 / 9卷
关键词
Cdk5; In silico; Methylation; Breast cancer; Prognosis; FASTK; Oncomine; TCGA;
D O I
暂无
中图分类号
学科分类号
摘要
Cyclin-dependent kinase 5 (Cdk5) functions as a tumor promoter in various types of cancer. Cdk5 is overexpressed in breast cancer patients. The prognostic significance of the Cdk5 gene and its expression in breast cancer were analyzed using various bioinformatic tools. Cdk5 gene expression in different breast cancer subtypes was analyzed using the Oncomine, UALCAN, and bcGenExMiner v4.2 websites. The correlation between Cdk5 mRNA expression and promoter methylation was established using TCGA datasets from the UCSC Xena and UALCAN websites. The relationship between Cdk5 promoter methylation and different clinicopathological parameters in breast cancer patients was determined using UALCAN. Cdk5 expression is associated with various clinicopathological parameters, such as estrogen receptor, progesterone receptor, the basal-like subtype, and triple-negative breast cancer, which was analyzed using bcGenExMiner v4.2. Kaplan–Meier plotter revealed high Cdk5 expression and poor survival in breast cancer patients. In addition, a list of genes that are coexpressed with Cdk5 in breast cancer was identified from the UALCAN website. From that list, we observed that Fas-activated serine/threonine kinase (FASTK) has a predominant positive correlation with Cdk5 in breast cancer. The UCSC Xena and bcGenExMiner v4.2 websites were used to confirm the correlation between Cdk5 and FASTK. Cdk5 overexpression might induce malignancies and is associated with a poor prognosis in breast cancer patients through FASTK. Therefore, Cdk5 might act as a biomarker to predict the prognosis of breast cancer.
引用
收藏
相关论文
共 208 条
  • [1] Al-Hajj M(2003)Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci 100 3983-3988
  • [2] Wicha MS(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [3] Benito-Hernandez A(2009)FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion J Cell Biol 185 357-370
  • [4] Morrison SJ(2017)UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses Neoplasia 19 649-658
  • [5] Clarke MF(2019)Bioinformatics analysis revealing prognostic significance of RRM2 gene in breast cancer Biosci Rep 39 BSR20182062-9668
  • [6] Bray F(2005)Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation J Neurosci 25 9658-2866
  • [7] Ferlay J(2012)Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway Mol Biol Cell 23 2856-74
  • [8] Soerjomataram I(1994)Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes Cytogenet Genome Res 66 72-6150
  • [9] Siegel RL(2001)A decade of CDK5 Nat Rev Mol Cell Biol 2 749-e289
  • [10] Torre LA(2011)Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras Clin Cancer Res 17 6140-4469